CSL Carlisle Companies (CSL) Insider Trading, Ownership & Congress Trades
Materials · Fabricated rubber products, nec · CIK 0000790051
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
1
Codes C/M, not in net · no price filed
What the filings say about CSL
Congress, 1 year
No trades
Last one: sale, 2025-08-04
Carlisle Companies insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for CARLISLE COMPANIES INC in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 25.2% of the 926 shares held after it.
- 4 other insiders sold within 30 days.
Insider activity: VP & Chief Accounting Officer Easton Andrew C sold about $95.0K of CSL on Feb 19, 2026; 4 other insiders sold within 30 days.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Feb 8, 2024.
- The trade is 11.5% of the 13,089 shares held after it.
- 4 other insiders sold within 30 days.
Insider activity: Vice Chair of CCM Schwar Stephen sold about $625.7K of CSL on Feb 12, 2026; 4 other insiders sold within 30 days.Context
- 4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Feb 8, 2024.
- The trade is 53.3% of the 8,540 shares held after it.
- 4 other insiders sold within 30 days.
Insider activity: Vice Chair of CCM Schwar Stephen sold about $1.9M of CSL on Feb 12, 2026; 4 other insiders sold within 30 days.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Jul 26, 2024.
- The trade is 0.7% of the 30,094 shares held after it.
- 4 other insiders sold within 30 days.
Insider activity: VP & Chief Financial Officer Zdimal Kevin P sold about $83.5K of CSL on Feb 10, 2026, the largest insider sale at the company since 2025; 4 other insiders sold within 30 days.Context
- 16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Jul 26, 2024.
- The trade is 8.4% of the 30,294 shares held after it.
- 4 other insiders sold within 30 days.
Insider activity: VP & Chief Financial Officer Zdimal Kevin P sold about $1.1M of CSL on Feb 10, 2026, the largest insider sale at the company since 2024; 4 other insiders sold within 30 days.110 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+0.3% year over year
below 51% of Materials
Margin
14.8% net margin
more than 89% of Materials
Buybacks
$500.0M repurchased, FY to 2026-06-30
more than 96% of Materials
Short interest
5.2% of the float short (float per yahoo 2026-10-27) · 4.7 days to cover · settled 2026-10-15
more than 67% of Materials
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch CSL
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+3.2%12M
Insider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns CSL: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in CSL
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-08-04 · disclosed 39 days later
$1,001 - $15,000
Bought 2025-06-17 · disclosed 57 days later
$1,001 - $15,000
Sold 2025-04-07 · disclosed 37 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
CSL planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · D. Christian Koch
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$11.4M
$2.0M
$2.3M
+116%
+55%
2024
$14.2M
$22.3M
$3.6M
+146%
+44%
2023
$11.0M
$22.4M
$2.8M
+107%
+26%
2022
$11.5M
$10.8M
$2.8M
+54%
+8%
2021
$11.0M
$33.2M
$3.1M
+61%
+25%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
CSL financials
Revenue growth
+0.3%
XBRL, annual
Net margin
14.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$5.1B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM CSL
| FY Dec 2025 | $5.0B |
| FY Dec 2024 | $5.0B |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | $1.6B |
| Mar 2026 | $1.1B |
| Dec 2025 | $1.1B |
| Sep 2025 | $1.3B |
| Jun 2025 | $1.4B |
| Mar 2025 | $1.1B |
| Dec 2024 | $1.1B |
| Sep 2024 | $1.3B |
At each fiscal year end
Single quarter
Net margin, TTM
+14.2%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM CSL
| FY Dec 2025 | +14.8% |
| FY Dec 2024 | +26.2% |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | +16.3% |
| Mar 2026 | +12.1% |
| Dec 2025 | +11.3% |
| Sep 2025 | +15.9% |
| Jun 2025 | +17.6% |
| Mar 2025 | +13.1% |
| Dec 2024 | +14.5% |
| Sep 2024 | +18.3% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$866.6M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CSL
| FY Dec 2025 | $970.6M |
| FY Dec 2024 | $917.0M |
| FY Dec 2023 | $1.1B |
| FY Dec 2022 | $817.4M |
| FY Dec 2021 | $286.9M |
| Jun 2026 | $200.1M |
| Mar 2026 | -$73.0M |
| Dec 2025 | $346.1M |
| Sep 2025 | $393.4M |
| Jun 2025 | $258.3M |
| Mar 2025 | -$27.2M |
| Dec 2024 | $334.0M |
| Sep 2024 | $293.5M |
At each fiscal year end
Single quarter
Debt to equity
1.79x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity CSL
| FY Dec 2025 | 1.61x |
| FY Dec 2024 | 0.77x |
| FY Dec 2023 | 0.81x |
| FY Dec 2022 | 0.85x |
| FY Dec 2021 | 1.11x |
| Jun 2026 | 1.79x |
| Mar 2026 | 1.75x |
| Dec 2025 | 1.61x |
| Sep 2025 | 1.45x |
| Jun 2025 | 0.89x |
| Mar 2025 | 0.87x |
| Dec 2024 | 0.77x |
| Sep 2024 | 0.83x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.35x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt CSL
| FY Dec 2025 | 0.38x |
| FY Dec 2024 | 0.54x |
| FY Dec 2023 | 0.52x |
| FY Dec 2022 | 0.39x |
| FY Dec 2021 | 0.14x |
| Jun 2026 | 0.35x |
| Mar 2026 | 0.37x |
| Dec 2025 | 0.38x |
| Sep 2025 | 0.38x |
| Jun 2025 | 0.51x |
| Mar 2025 | 0.46x |
| Dec 2024 | 0.54x |
| Sep 2024 | 0.46x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+38.8%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CSL
| FY Dec 2025 | +34.8% |
| FY Dec 2024 | +49.6% |
| FY Dec 2023 | +26.2% |
| FY Dec 2022 | +32.7% |
| FY Dec 2021 | +16.3% |
| Jun 2026 | +38.8% |
| Mar 2026 | +38.0% |
| Dec 2025 | +34.8% |
| Sep 2025 | +32.6% |
| Jun 2025 | +31.5% |
| Mar 2025 | +50.3% |
| Dec 2024 | +49.6% |
| Sep 2024 | +47.6% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+12.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CSL
| FY Dec 2025 | +12.3% |
| FY Dec 2024 | +21.1% |
| FY Dec 2023 | +11.1% |
| FY Dec 2022 | +12.8% |
| FY Dec 2021 | +6.4% |
| Jun 2026 | +12.3% |
| Mar 2026 | +12.7% |
| Dec 2025 | +12.3% |
| Sep 2025 | +12.0% |
| Jun 2025 | +13.2% |
| Mar 2025 | +20.9% |
| Dec 2024 | +21.1% |
| Sep 2024 | +20.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+17.9%
operating income after a 22.7% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital CSL
| FY Dec 2025 | +19.2% |
| FY Dec 2024 | +23.0% |
| FY Dec 2023 | +16.0% |
| FY Dec 2022 | n/a |
| FY Dec 2021 | +9.2% |
| Jun 2026 | +17.9% |
| Mar 2026 | +18.1% |
| Dec 2025 | +19.2% |
| Sep 2025 | +20.7% |
| Jun 2025 | +23.4% |
| Mar 2025 | +21.3% |
| Dec 2024 | +23.0% |
| Sep 2024 | +25.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+20.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed CSL
| FY Dec 2025 | +18.8% |
| FY Dec 2024 | +21.6% |
| FY Dec 2023 | +17.0% |
| FY Dec 2022 | +19.7% |
| FY Dec 2021 | +10.2% |
| Jun 2026 | +20.0% |
| Mar 2026 | +19.5% |
| Dec 2025 | +18.8% |
| Sep 2025 | +18.7% |
| Jun 2025 | +20.2% |
| Mar 2025 | +21.3% |
| Dec 2024 | +21.6% |
| Sep 2024 | +20.7% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
19.80x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CSL
| FY Dec 2025 | 18.65x |
| FY Dec 2024 | 13.28x |
| FY Dec 2023 | 20.50x |
| FY Dec 2022 | 13.43x |
| FY Dec 2021 | 31.33x |
| Jun 2026 | 20.76x |
| Mar 2026 | 19.57x |
| Dec 2025 | 18.65x |
| Sep 2025 | 18.50x |
| Jun 2025 | 20.69x |
| Mar 2025 | 12.61x |
| Dec 2024 | 13.28x |
| Sep 2024 | 15.91x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$16.0B
market value at close 2026-10-26 on 2026-07-23 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value CSL
| FY Dec 2025 | $15.1B |
| FY Dec 2024 | $17.9B |
| FY Dec 2023 | $16.9B |
| FY Dec 2022 | $14.4B |
| FY Dec 2021 | $15.6B |
| Jun 2026 | $16.9B |
| Mar 2026 | $15.8B |
| Dec 2025 | $15.1B |
| Sep 2025 | $15.8B |
| Jun 2025 | $18.0B |
| Mar 2025 | $16.8B |
| Dec 2024 | $17.9B |
| Sep 2024 | $21.6B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+6.3%
TTM free cash flow over market value at close 2026-10-26
FCF yield CSL
| FY Dec 2025 | +7.3% |
| FY Dec 2024 | +5.5% |
| FY Dec 2023 | +7.0% |
| FY Dec 2022 | +6.7% |
| FY Dec 2021 | +2.2% |
| Jun 2026 | +5.9% |
| Mar 2026 | +6.8% |
| Dec 2025 | +7.3% |
| Sep 2025 | +6.8% |
| Jun 2025 | +5.3% |
| Mar 2025 | +5.0% |
| Dec 2024 | +5.5% |
| Sep 2024 | +4.5% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -3%, PEG needs growth
PEG, trailing CSL
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.16x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.11x |
| FY Dec 2021 | 0.86x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | 0.22x |
| Dec 2024 | 0.16x |
| Sep 2024 | 0.16x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $5.0B | $5.0B | $4.6B | $6.6B |
| Gross profit | n/a | n/a | $1.6B | $1.9B |
| Operating income | $1.0B | $1.1B | $982.8M | $1.2B |
| Net income | $740.7M | $1.3B | $767.4M | $924.0M |
| EPS (diluted) | 17.12 | 27.82 | 15.18 | 17.56 |
| Operating cash flow | $1.1B | $1.0B | $1.2B | $1.0B |
| Cash | $1.1B | $753.5M | $576.7M | $364.8M |
| Long-term debt | $2.9B | $1.9B | $1.9B | $2.3B |
| Buybacks | $1.3B | $1.6B | $900.0M | $400.0M |
| Dividends paid | $181.1M | $172.4M | $160.3M | $134.4M |
SEC XBRL, fiscal years, as known on 2026-10-28
CSL Stock Sonar score 5/7 axes
Find similar shapesCompareCSL ranks highest on profitability (88th percentile) and risk and compliance (51st), and lowest on financial health (43rd), among Materials peers.
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CSL filings, in plain words
Have members of Congress traded CSL?
Yes, but not in the year to 2026-10-28; the latest on record is a sale by Lisa McClain dated 2025-08-04.
Read the full summary
Members of Congress have disclosed trades in CSL, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-08-04. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
